Penserra Capital Management LLC Xenon Pharmaceuticals Inc. Transaction History

Penserra Capital Management LLC

  • $4.61 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$15.6 - $35.4 $14,664 - $33,276
-940 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$14.86 - $19.45 $74 - $97
5 Added 0.53%
940 $14,000
Q2 2021

Aug 12, 2021
BUY
$16.81 - $20.0 $2,353 - $2,800
140 Added 17.61%
935 $17,000
Q1 2021

May 13, 2021
SELL
$13.65 - $21.31 $136 - $213
-10 Reduced 1.24%
795 $14,000
Q4 2020

Feb 12, 2021
BUY
$9.49 - $16.04 $7,639 - $12,912
805 New
805 $12,000

Others Institutions Holding XENE

# of Institutions
212
Shares Held
70.2M
Call Options Held
88.3K
Put Options Held
28.8K
View Full List

About Xenon Pharmaceuticals Inc.

XENE Quotes by TradingView
  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.39B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email